Esterline Technologies Corporation (ESL): Insiders Are Buying This Defense Stock, But Should You?

Page 1 of 2

Esterline Technologies Corporation (NYSE:ESL) is a leading world-wide supplier to the aerospace and defense industry, specializing in three core areas: Avionics & Controls, Sensors & Systems, and Advanced Materials. Recent significant insider buying has been reported at the company. Should investors follow the insiders and buy the stock?

Valuation

With regards to valuation, Esterline trades at a P/E of 19.51, close to the industry average. Its price-to-earnings ratio is lower than that of competitors like AMETEK, Inc. (NYSE:AME), but higher than that of others like Lockheed Martin Corporation (NYSE:LMT). The situation is similar when taking into account future earning estimates:
Esterline Technologies Corporation (NYSE:ESL)’s forward P/E is 11.59, sitting halfway between AMETEK’s 17.40, and Lockheed’s 10.67. However, the situation is different when one looks at the stock’s PEG and P/B: Esterline beats its competitors in both ratios (the stock is trading at a P/B of 1.34 and a PEG of 1.30). All in all, Esterline is neither overvalued nor undervalued when taking into account price-to-earning ratios (both current and forward), but, relative to its peers and industry, the stock does seem to be slightly undervalued when taking into account its price-to-book and P/E-to-growth (PEG) ratios.

Analysts

Wall Street analysts are slightly bullish on the stock: it currently has an average recommendation of 2.20 (overweight-hold) and an average price target of $76.89, which implies 7.7% upside potential from current prices. However, AMETEK, Inc. (NYSE:AME) seems to be the most favored by analysts, as it has an average recommendation of 1.90 (buy-overweight), and a price target that implies more than a 13% upside potential. With regards to Lockheed Martin Corporation (NYSE:LMT), even though it beat most of the industry’s stocks in the P/E arena, analysts are mostly neutral on this one: the stock has a 2.80 average recommendation, and its average price target is actually lower than the current stock price.

P/E Fw P/E P/B PEG Avg Rec Avg PT (%implied upside) Div Yield
ESL 19.51 11.59 1.34 1.30 2.20 $76.89 (+7.7%) N/A
AME 21.38 17.40 3.86 1.52 1.90 $45.56 (+13.33%) 0.60%
LMT 11.50 10.67 802 1.59 2.80 $95.67 (-0.63%) 4.78%
Edge LMT LMT ESL ESL AME AME LMT

Price movements

Despite defense spending reduction fears, Esterline Technologies Corporation (NYSE:ESL) has had a good run YTD, as the stock has gained roughly 12.5%. Its price has dropped from its 52-week high attained in mid-March (it is currently 8.36% off its high of $77.90), but it is almost 40% above its 52-week lows of $51.13. The stock is also trading close to its all-time high of $80.57 (July 2011) and far from its low of $19.76, which was reached in March 2009 amid the financial crisis.

Insider buying

On April 11, Director Henry Ward Winship IV bought 18,500 shares of Esterline Technologies in the open market, at an average price of $75.56. That is a purchase of almost $1.4 million. The next day, he bought 9,500 more shares, at an average price of $75.12, spending more than $700,000. So in just two days, Mr. Winship, a director with unique insight into the company’s business, invested $2,111,500 of his own money to buy Esterline Technologies Corporation (NYSE:ESL) shares in the open market. This is significant insider buying, and is therefore a bullish sign for the stock.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!